Breaking

Syntholene Energy
Application for EU Strategic Project Designation for Black Schist Ni-Cu-Co-Zn Project, Finland
Sirios Adds $1.5 Million to the Treasury After Warrant and Option Exercises
American Eagle Continues to Expand South Zone near Surface Mineralization: Highlights Include 140 m of 0.74% Copper Eq. and 130 m of 0.62% Copper Eq.
Freegold Drills 1.28 g/t Au over 49.3m in New Tamarack Zone at Golden Summit and 0.91 g/t Au Over 150.9m at Cleary
Angkor Resources Advances Exploration On CZ Gold And Wild Boar Prospects, Andong Meas License, Cambodia
African Discovery Group Announces Shareholder Approval of Butembo Merger Agreement
S&P Global: Fragmented Climate and Energy Strategies Will Define 2026

Facebook
Twitter
Google Plus
Instagram
Pinterest
Vimeo

Investing
Stock
Latest News
Editor’s Pick
Economy
Search for:

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

By June 4, 2025

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Syntholene Energy

January 15, 2026

Application for EU Strategic Project Designation for Black Schist Ni-Cu-Co-Zn Project, Finland

January 15, 2026

Sirios Adds $1.5 Million to the Treasury After Warrant and Option Exercises

January 15, 2026

Enter Your Information Below To Receive Latest News, And Articles.
Your name

Your email
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest Posts
Categories
- Economy (1,040)
- Editor's Pick (701)
- Investing (5,768)
- Latest News (3,536)
- Stock (1,161)
About Rightinvestingway

Disclaimer: Rightinvestingway.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 Rightinvestingway.com

Top

Type above and press Enter to search. Press Esc to cancel.